Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks

Published:2021-06-26 Issue:18 Volume:9 Page:4690-4699
ISSN:2307-8960
Container-title:World Journal of Clinical Cases
language:
Short-container-title:WJCC

Author:

Chen Xiao-Fan,Fan Ya-Nan,Si Chong-Wen,Yu Yan-Yan,Shang Jia,Yu Zu-Jiang,Mao Qing,Xie Qing,Zhao Wei,Li Jun,Gao Zhi-Liang,Wu Shan-Ming,Tang Hong,Cheng Jun,Chen Xin-Yue,Zhang Wen-Hong,Wang Hao,Xu Zhong-Nan,Wang Ling,Dai Jun,Xu Jing-Hang

Publisher

Baishideng Publishing Group Inc.

Subject

General Medicine

Reference16 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. Viral Suppression and Cirrhosis Regression with Tenofovir Disoproxil Fumarate in Asians with Chronic Hepatitis B

3. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B

4. The global burden of liver disease: The major impact of China

5. Management of chronic hepatitis B infection

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP